TBC1D24

TBC1D24 is a gene that encodes a protein of the same name in humans. The TBC1D24 protein is involved in various cellular processes, including cell growth, cell differentiation, and signal transduction. Mutations in this gene have been associated with a range of neurological disorders, including epilepsy, hearing loss, and DOORS syndrome.

Function

The TBC1D24 gene belongs to the TBC1 domain family, which is characterized by a conserved domain of approximately 200 amino acids. This domain is known to have GTPase-activating protein (GAP) activity towards small G proteins of the Rab family, which are involved in vesicle trafficking within cells.

The TBC1D24 protein is thought to play a role in the regulation of membrane trafficking and signal transduction, contributing to various cellular processes such as cell growth and differentiation. It is also involved in the development and function of the nervous system, particularly in the brain and auditory system.

Clinical significance

Mutations in the TBC1D24 gene have been linked to several neurological disorders. These include:

• Epilepsy: Certain mutations in TBC1D24 are associated with various forms of epilepsy, including familial infantile myoclonic epilepsy and focal epilepsy.
• Hearing loss: Some TBC1D24 mutations can cause nonsyndromic hearing loss, a type of hearing loss that is not associated with other signs and symptoms.
• DOORS syndrome: This is a rare genetic disorder characterized by deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures. It is caused by mutations in the TBC1D24 gene.

Research

Research into the TBC1D24 gene and its associated protein is ongoing, with the aim of better understanding their roles in cellular processes and disease. This could potentially lead to the development of new treatments for the neurological disorders associated with TBC1D24 mutations.